The Chemours Company
CCNYSEBasic Materials● Active
$20.81
+$0.31(+1.49%)
Market Cap$3.1B
P/E Ratio—
52W High$28.67
52W Low$10.14
The Chemours Company (CC) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CC · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 5, 2026EPS Actual
$0.05
Est. -$0.05 · +200.0%
Revenue
$1.38B
Est. $1.40B · -1.3%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 5, 2026
After Market Close
▲ Beat EPS▼ Miss Revenue✓ 1-Quarter EPS Beat Streak
CC reports quarterly as a NYSE-listed Chemicals - Specialty company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.37
Rev. $0.36B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.37
Rev. Est.$0.36B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 4, 2026 | $0.48 | — | — | — | $1.65B | — |
| ▲ Q2 FY2026 | May 5, 2026 | -$0.05 | $0.05 | +200.0% | $1.38B | $1.40B | -1.3% |
| ▼ Q1 FY2026 | Feb 19, 2026 | $0.09 | $0.05 | -43.6% | $1.33B | $1.33B | +0.0% |
| ▼ Q4 FY2025 | Nov 6, 2025 | $0.24 | $0.20 | -16.7% | $1.50B | $1.33B | +12.5% |
| ▲ Q3 FY2025 | Aug 5, 2025 | $0.46 | $0.58 | +26.1% | $1.61B | $1.54B | +4.7% |
| ▼ Q2 FY2025 | May 6, 2025 | $0.19 | $0.13 | -31.6% | $1.37B | $1.35B | +1.2% |
| ▲ Q1 FY2025 | Feb 18, 2025 | $0.10 | $0.11 | +10.0% | $1.39B | $1.38B | +0.8% |
| ▲ Q4 FY2024 | Nov 4, 2024 | $0.32 | $0.40 | +25.0% | $1.50B | $1.35B | +11.0% |
Q3 FY2026
Aug 4, 2026
EPS Actual
—
EPS Est.
$0.48
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 5, 2026Beat
EPS Actual
$0.05
EPS Est.
-$0.05
EPS Surpr.
+200.0%
Revenue
$1.38B
Q1 FY2026
Feb 19, 2026Miss
EPS Actual
$0.05
EPS Est.
$0.09
EPS Surpr.
-43.6%
Revenue
$1.33B
Q4 FY2025
Nov 6, 2025Miss
EPS Actual
$0.20
EPS Est.
$0.24
EPS Surpr.
-16.7%
Revenue
$1.50B
Q3 FY2025
Aug 5, 2025Beat
EPS Actual
$0.58
EPS Est.
$0.46
EPS Surpr.
+26.1%
Revenue
$1.61B
Q2 FY2025
May 6, 2025Miss
EPS Actual
$0.13
EPS Est.
$0.19
EPS Surpr.
-31.6%
Revenue
$1.37B
Q1 FY2025
Feb 18, 2025Beat
EPS Actual
$0.11
EPS Est.
$0.10
EPS Surpr.
+10.0%
Revenue
$1.39B
Q4 FY2024
Nov 4, 2024Beat
EPS Actual
$0.40
EPS Est.
$0.32
EPS Surpr.
+25.0%
Revenue
$1.50B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.42 | $0.43 | $0.45 | 3 |
| Q3 FY2028 | $0.87 | $0.90 | $0.94 | 3 |
| Q2 FY2028 | $0.95 | $0.98 | $1.03 | 3 |
| Q1 FY2028 | $0.58 | $0.60 | $0.63 | 3 |
| Q4 FY2027 | $0.29 | $0.30 | $0.32 | 2 |
| Q3 FY2027 | $0.76 | $0.79 | $0.82 | 2 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $1.5B | $1.5B | $1.6B | 1 |
| Q3 FY2028 | $1.7B | $1.7B | $1.8B | 1 |
| Q2 FY2028 | $1.8B | $1.8B | $1.9B | 1 |
| Q1 FY2028 | $1.5B | $1.6B | $1.6B | 1 |
| Q4 FY2027 | $1.4B | $1.5B | $1.5B | 2 |
| Q3 FY2027 | $1.6B | $1.7B | $1.7B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 5, 2026 | +200.0% | $27.22 | $27.94 | +2.65% |
| ▼ Q1 FY2026 | Feb 19, 2026 | -43.6% | $21.15 | $20.41 | -3.50% |
| ▼ Q4 FY2025 | Nov 6, 2025 | -16.7% | $12.05 | $11.74 | -2.57% |
| ▲ Q3 FY2025 | Aug 5, 2025 | +26.1% | $12.21 | $12.63 | +3.44% |
| ▼ Q2 FY2025 | May 6, 2025 | -31.6% | $12.10 | $12.10 | +0.00% |
| ▲ Q1 FY2025 | Feb 18, 2025 | +10.0% | $16.83 | $17.48 | +3.86% |
| ▲ Q4 FY2024 | Nov 4, 2024 | +25.0% | $17.82 | $20.58 | +15.49% |
| ▼ Q3 FY2024 | Aug 1, 2024 | -33.3% | $24.17 | $23.31 | -3.56% |
Q2 FY2026+2.65%
Report Date
May 5, 2026
EPS Beat/Miss
+200.0%
Price Before
$27.22
Price After
$27.94
Q1 FY2026-3.50%
Report Date
Feb 19, 2026
EPS Beat/Miss
-43.6%
Price Before
$21.15
Price After
$20.41
Q4 FY2025-2.57%
Report Date
Nov 6, 2025
EPS Beat/Miss
-16.7%
Price Before
$12.05
Price After
$11.74
Q3 FY2025+3.44%
Report Date
Aug 5, 2025
EPS Beat/Miss
+26.1%
Price Before
$12.21
Price After
$12.63
Q2 FY2025+0.00%
Report Date
May 6, 2025
EPS Beat/Miss
-31.6%
Price Before
$12.10
Price After
$12.10
Q1 FY2025+3.86%
Report Date
Feb 18, 2025
EPS Beat/Miss
+10.0%
Price Before
$16.83
Price After
$17.48
Q4 FY2024+15.49%
Report Date
Nov 4, 2024
EPS Beat/Miss
+25.0%
Price Before
$17.82
Price After
$20.58
Q3 FY2024-3.56%
Report Date
Aug 1, 2024
EPS Beat/Miss
-33.3%
Price Before
$24.17
Price After
$23.31
Avg Beat Reaction+6.36%
Avg Miss Reaction-2.41%
Beat Rate4 / 8 quarters
Largest Move+15.49% (Q4 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CC ends December
The Chemours Company (CC) most recently reported earnings on May 5, 2026 for Q2 FY2026, posting EPS of $0.05 — beating the analyst consensus of $-0.05 by +200.0%. The next CC earnings date is expected around September 1, 2026.
Each quarter, investors track CC earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CC revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CC's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CC earnings · 5 questionsThe Chemours Company's next earnings report is expected around September 1, 2026. CC typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CC historically reports after market close (AMC).
CC earnings datewhen is CC earningsCC next earnings datewhen does CC report earningsCC earnings calendar
▸ Source: FMP · The Chemours Company SEC filings · US GAAP · The Chemours Company SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026